These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity. Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; Goldstone AP; Martin NM; Todd JF; Palazzo F; Tan T Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961 [TBL] [Abstract][Full Text] [Related]
5. The utility of Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Havekes B; Eisenhofer G; Martiniova L; Adams KT; Pacak K J Clin Endocrinol Metab; 2009 Dec; 94(12):4757-67. PubMed ID: 19864450 [TBL] [Abstract][Full Text] [Related]
7. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study. Singh D; Shukla J; Walia R; Vatsa R; Paul N; Chhabra A; Nahar U; Singh H; Kumar R; Bhansali A; Rai Mittal B Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602 [TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204 [TBL] [Abstract][Full Text] [Related]
11. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 18 F-MFBG and 68 Ga-DOTATATE PET/CT in the Imaging of Metastatic Paraganglioma and Pheochromocytoma. Deng M; Shu Q; Hu M; Chen Y; Cai L Clin Nucl Med; 2022 Dec; 47(12):e735-e737. PubMed ID: 35777982 [TBL] [Abstract][Full Text] [Related]
13. Clinical, Diagnostic, and Treatment Characteristics of Jha A; de Luna K; Balili CA; Millo C; Paraiso CA; Ling A; Gonzales MK; Viana B; Alrezk R; Adams KT; Tena I; Chen A; Neuzil J; Raygada M; Kebebew E; Taieb D; O'Dorisio MS; O'Dorisio T; Civelek AC; Stratakis CA; Mercado-Asis L; Pacak K Front Oncol; 2019; 9():53. PubMed ID: 30854332 [No Abstract] [Full Text] [Related]
14. Genetic status determines Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398 [TBL] [Abstract][Full Text] [Related]
15. Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Rufini V; Treglia G; Castaldi P; Perotti G; Giordano A Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):122-33. PubMed ID: 23822989 [TBL] [Abstract][Full Text] [Related]
16. Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease. Kroiss AS Wien Med Wochenschr; 2019 Feb; 169(1-2):25-32. PubMed ID: 30182289 [TBL] [Abstract][Full Text] [Related]
17. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618 [TBL] [Abstract][Full Text] [Related]
18. 18 F-MFBG PET/CT Is an Effective Alternative of 68 Ga-DOTATATE PET/CT in the Evaluation of Metastatic Pheochromocytoma and Paraganglioma. Wang P; Li T; Cui Y; Zhuang H; Li F; Tong A; Jing H Clin Nucl Med; 2023 Jan; 48(1):43-48. PubMed ID: 36252940 [TBL] [Abstract][Full Text] [Related]
19. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT. Fikri AS; Kroiss A; Ahmad AZ; Zanariah H; Lau WF; Uprimny C; Donnemiller E; Kendler D; Nordin AJ; Virgolini IJ Acta Radiol; 2014 Jun; 55(5):631-40. PubMed ID: 24037430 [TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Naswa N; Sharma P; Nazar AH; Agarwal KK; Kumar R; Ammini AC; Malhotra A; Bal C Eur Radiol; 2012 Mar; 22(3):710-9. PubMed ID: 21971823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]